Fertility treatment isn’t linked to an increased risk of ovarian cancer, according to a National Cancer Institute (NCI)-supported study spanning nearly two decades and published in Fertility and Sterility.
Fertility treatment isn’t linked to an increased risk of ovarian cancer, according to a National Cancer Institute (NCI)-supported study spanning nearly two decades and published in Fertility and Sterility.
Researchers from the Division of Cancer Epidemiology and Genetics at the NCI analyzed data from 9825 women seen for infertility at 5 large practices in the United States from 1965 to 1988. Researchers followed women who developed ovarian cancer (n=85) for an average of 17.6 years and women who did not develop cancer for an average of 26.2 years.
Among the cohort, no association was seen between ovarian cancer and clomiphene citrate (CC) (adjusted hazard ratio [RR] 1.34, 95% confidence interval [CI] 0.86-2.07) or gonadotropins (RR 1.00, 95% CI 0.48-2.08). No evidence was found to suggest an increased risk among the detailed subgroups of usage with one exception. Women who used CC and remained nulligravid demonstrated a significantly higher risk than those who conceived when compared with nonusers (RR 3.63, 95% CI 1.35 -9.72 versus RR 0.88, 95% CI 0.47-1.63).
The authors cautioned that the study evaluated the way drugs were used in the 1970s and 1980s, meaning that the findings could be of limited use for current treatment decisions because drug exposure then was significantly less. It also remains unclear, they said, why women who used CC and remained nulligravid were at higher risk of developing cancer, and urged further study.
To get weekly advice for today's Ob/Gyn, subscribe to the Contemporary Ob/Gyn Special Delivery.
Tocolysis use after PPROM not linked to neurodevelopmental outcomes
May 29th 2024A recent study investigated the effects of antenatal tocolysis on neurodevelopmental outcomes among children aged 5.5 years following preterm prelabor rupture of membranes, revealing no significant differences in outcomes.
Read More
Study finds youth with developmental disabilities less likely to access reproductive health care
May 22nd 2024A recent study reveals that adolescents with autism and other developmental disabilities have fewer visits to obstetrician-gynecologists and lower hormonal contraceptive use compared to their typically developing peers, highlighting a need for improved reproductive health services.
Read More
Rising endometriosis rates linked to increased pregnancy complications
May 19th 2024A new study presented at the 2024 ACOG meeting reveals a significant rise in endometriosis among pregnant women over the past 20 years, linking the condition to increased obstetric and neonatal complications.
Read More